Effectiveness, The Holy Grail of Compliance - Both the DOJ & OIG Weigh In

This article serves to compare and contrast the compliance guidelines as set forth by the DOJ and OIG within weeks of each other. More than 25 years have passed since U.S. Sentencing Commission put forth the now infamous seven elements of an effective compliance program. Since then, Compliance Officers continue to chase the “holy grail” of effectiveness. Unfortunately, determining whether a compliance program is effective and how to measure for effectiveness has proven both elusive and difficult. Compounding the challenge is that in the historical period, compliance program guidance has been limited and infrequent. But in the first quarter of 2017, in an unprecedented move, both the United States Department of Justice (“DOJ”) and Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) issued guidance on compliance programs. To Read the Full Story, Subscribe, Download a Sample Issue, or Sign In       Related StoriesAn FCA Journey - Allergan to Pay $53M to DOJThis is Not Your Parent’s Compliance Program – The New Era of Compliance Resourcing at Small to Mid-Size Pharmaceutical CompaniesThe 21st Century Cures Act: Is It Worth the Cost for Lifesciences? 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs